Anti CMV T Cells, HLA-A*0201 restricted

Description

Anti CMV T Cells, HLA-A*0201 restricted, are human T lymphocytes isolated from peripheral blood and specialized in targeting cytomegalovirus (CMV)-infected cells in individuals carrying the HLA-A0201 allele. Following the primary culture, these cells are cryopreserved. These T cells recognize viral peptides presented by the HLA-A*0201 molecule on the surface of infected cells, leading to their targeted destruction. Research has demonstrated that these cells can be utilized for adoptive immunotherapy to prevent or treat CMV-associated diseases, particularly in transplantation settings. In vitro, these cells show limited proliferation capacity, and repeated freezing and thawing during culture should be avoided. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.